Literature DB >> 8719033

Recent advances in molecular recognition and signal transduction of active peptides: receptors for opioid peptides.

B L Kieffer1.   

Abstract

1. Opioid peptides are a family of structurally related neuromodulators which play a major role in the control of nociceptive pathways. These peptides act through membrane receptors of the nervous system, defined as mu, delta and kappa and endowed with overlapping but distinct pharmacological, anatomical and functional properties. 2. Recent cloning of an opioid receptor gene family has opened the way to the use of recombinant DNA technology at the receptor level. 3. This review focuses on the molecular cloning and functional characterization of opioid receptors and provides first insights into molecular aspects of opioid peptide recognition and signal transduction mechanisms, using the cloned receptors as investigation tools.

Mesh:

Substances:

Year:  1995        PMID: 8719033     DOI: 10.1007/BF02071128

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  85 in total

Review 1.  Endogenous and exogenous opioids in the control of gastrointestinal motility and secretion.

Authors:  W Kromer
Journal:  Pharmacol Rev       Date:  1988-06       Impact factor: 25.468

2.  The cloned kappa opioid receptor couples to an N-type calcium current in undifferentiated PC-12 cells.

Authors:  M Tallent; M A Dichter; G I Bell; T Reisine
Journal:  Neuroscience       Date:  1994-12       Impact factor: 3.590

3.  Primary structure and functional expression of a rat G-protein-coupled muscarinic potassium channel.

Authors:  Y Kubo; E Reuveny; P A Slesinger; Y N Jan; L Y Jan
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

4.  Expression of two variants of the human mu opioid receptor mRNA in SK-N-SH cells and human brain.

Authors:  L A Bare; E Mansson; D Yang
Journal:  FEBS Lett       Date:  1994-11-07       Impact factor: 4.124

5.  The human delta-opioid receptor: genomic organization, cDNA cloning, functional expression, and distribution in human brain.

Authors:  F Simonin; K Befort; C Gavériaux-Ruff; H Matthes; V Nappey; B Lannes; G Micheletti; B Kieffer
Journal:  Mol Pharmacol       Date:  1994-12       Impact factor: 4.436

6.  Stereospecific binding of the potent narcotic analgesic (3H) Etorphine to rat-brain homogenate.

Authors:  E J Simon; J M Hiller; I Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-07       Impact factor: 11.205

7.  Agonist-induced desensitization of the mu opioid receptor-coupled potassium channel (GIRK1).

Authors:  A Kovoor; D J Henry; C Chavkin
Journal:  J Biol Chem       Date:  1995-01-13       Impact factor: 5.157

8.  Characterization and distribution of a cloned rat mu-opioid receptor.

Authors:  J R Bunzow; G Zhang; C Bouvier; C Saez; O K Ronnekleiv; M J Kelly; D K Grandy
Journal:  J Neurochem       Date:  1995-01       Impact factor: 5.372

9.  ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization.

Authors:  C Mollereau; M Parmentier; P Mailleux; J L Butour; C Moisand; P Chalon; D Caput; G Vassart; J C Meunier
Journal:  FEBS Lett       Date:  1994-03-14       Impact factor: 4.124

10.  Differential regulation by cAMP-dependent protein kinase and protein kinase C of the mu opioid receptor coupling to a G protein-activated K+ channel.

Authors:  Y Chen; L Yu
Journal:  J Biol Chem       Date:  1994-03-18       Impact factor: 5.157

View more
  73 in total

1.  G-protein-coupled receptor heterodimerization modulates receptor function.

Authors:  B A Jordan; L A Devi
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

2.  Transcriptional regulation of mouse delta-opioid receptor gene.

Authors:  H C Liu; J T Shen; L B Augustin; J L Ko; H H Loh
Journal:  J Biol Chem       Date:  1999-08-13       Impact factor: 5.157

3.  Effects of centrally administered endocannabinoids and opioids on orofacial pain perception in rats.

Authors:  Marek Zubrzycki; Anna Janecka; Andreas Liebold; Mechthild Ziegler; Maria Zubrzycka
Journal:  Br J Pharmacol       Date:  2017-08-30       Impact factor: 8.739

4.  beta-Endorphin expression in the mouse retina.

Authors:  Shannon K Gallagher; Paul Witkovsky; Michel J Roux; Malcolm J Low; Veronica Otero-Corchon; Shane T Hentges; Jozsef Vigh
Journal:  J Comp Neurol       Date:  2010-08-01       Impact factor: 3.215

5.  Pain imaging in the emerging era of molecular medicine.

Authors:  Christian S Stohler; Jon-Kar Zubieta
Journal:  Methods Mol Biol       Date:  2010

6.  Dopaminergic amacrine cells express opioid receptors in the mouse retina.

Authors:  Shannon K Gallagher; Julia N Anglen; Justin M Mower; Jozsef Vigh
Journal:  Vis Neurosci       Date:  2012-05       Impact factor: 3.241

7.  Electroencephalographic and convulsant effects of the delta opioid agonist SNC80 in rhesus monkeys.

Authors:  Ingela Danielsson; Maciej Gasior; Glenn W Stevenson; John E Folk; Kenner C Rice; S Stevens Negus
Journal:  Pharmacol Biochem Behav       Date:  2006-11-15       Impact factor: 3.533

Review 8.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

Review 9.  Targeting opioid receptor heterodimers: strategies for screening and drug development.

Authors:  Achla Gupta; Fabien M Décaillot; Lakshmi A Devi
Journal:  AAPS J       Date:  2006-03-10       Impact factor: 4.009

10.  A combined ligand-based and target-based drug design approach for G-protein coupled receptors: application to salvinorin A, a selective kappa opioid receptor agonist.

Authors:  Nidhi Singh; Gwénaël Chevé; David M Ferguson; Christopher R McCurdy
Journal:  J Comput Aided Mol Des       Date:  2006-09-29       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.